InstructorRoyed Training
TypeOnline Course
Price$490 / 34300 INR.
Buy NowBook Now
Loading
Free Resource at royedtraining

Sign Up Now

Create your account for free. Scale up your knowledge with Simulation based microlearning, case studies, lectures and self assessment tests.

Free Sign Up

asean drug regulatory affairs course

Introduction

who should attend

Feature

Content

Related Courses

ASEAN drug regulatory affairs

The objective of ASEAN Drug Regulatory Affairs course is to provide training on Drug Regulatory Affairs and drug registration process in ASEAN countries.

ASEAN regulatory affairs course covers recent pharmaceutical regulations, drug approval procedure, country specific Common Technical Documents requirement. Moreover, comprehensive idea is provided how to prepare drug dossier as per ACTD format. Above all, course briefs on strategic planning for registration of pharmaceutical, biopharmaceutical in ASEAN countries.

This online course utilizes interactive learning tools to guide each participant through to understand of the ASEAN regulatory structure and ensure that your submissions meet the standards required by the regulators. The course will focus on understanding of each specific countries regulations and registration norms. Importantly, course also provide specific requirements and structure of the registration dossier specific to each countries. As all the countries do not follow ACTD guideline. Rather, they suggest the changes in standard guideline. Hence, it will be important to understand guideline of each specific ASEAN countries.

The course provides practical based and interactive for effective understanding. Importantly, the course is designed to challenge students to apply what they have learned through the use of interactive exercises, reflection questions. As a result, it helps to build the competency of the participants.

Course Snapshots

  • Course Code: RYD-040
  • Title of the course: Advance Certification in ASEAN Drug Regulatory Affairs
  • Nature of the course: Online distance learning course. Therefore the course can be accessed online across anywhere 24×7.
  • Duration: 1 Month.
  • Eligibility: Graduation in any discipline. Even the final year student can join the course.
  • Course Certificate: Certificate will be provided at the end of the successful completion of the course.

Who should attend?

  • Regulatory Affairs professionals who are seeking to improve their skills in the ASEAN Drug Regulatory environment.
  • Those moving into regulatory affairs from other areas within a pharmaceutical company (Pharmacists, Clinical Trials, Marketing and others).
  • Regulatory Affairs, Registration and Documentation assistants/officers/managers.
  • Above all, this course is ideal for the business development managers working in pharmaceutical company, who are handling pharmaceutical business in European Union.

This ASEAN Drug Regulatory Affairs online course utilizes interactive learning tools to guide each participant through to understand of the regulatory process of the ASEAN pharmaceutical market. Moreover, this online certification course will focus on understanding regulatory affairs strategic management skills which is required for effective functioning as regulatory personnel. Indeed, advance simulation in the course will challenge students to apply what they have learned from the course. In addition, there are advance learning tools like interactive exercises, reflection questions, expert live chat which makes the course very interesting.

Key features of the course

  • Orientation to practical understanding in the entire drug regulation, registration procedure of each ASEAN countries. Moreover, course also focus on Common Technical Documents, guidelines and drug dossier preparations.
  • The course is self paced. Hence, course can be accessed 24×7, anytime, anywhere across the globe.
  • Moreover, students can download the course material hand out by login to dashboard. Hence, it helps them to study offline even after completion of the course.
  • Final examination is online. Hence, student can attend the final certification examination at own convenient date and time.

Course Content

The objective of this course is to impart knowledge and understanding of Drug Registration Procedure in ASEAN countries. Hence, the core focus will be on learning Drug Regulations, Drug Registration procedure, Country specific Common Technical Document, ACTD guidelines and dossier preparation.

This course is divided into following modules

  • Overview of the ASEAN countries : Country Introduction
  • Introduction to Drug Regulation and Registration Process of the each countries
  • Introduction to ASEAN Common Technical Document
  • Comparison Study of ACTD, ICH CTD and e-CTD.
  • Obtaining International GMP Certification and maintaining the GMP continuum.
  • Drug Dossier Preparation : Interactive Session
  • Drug Registration Process – Time Line (country specific)
  • Registration of Innovative Pharmaceutical Products in ASEAN countries
Section 1Fundamental of Drug Discovery Development and Commercialization
Lecture 1Introduction to Pharmaceutical R&D | Drug Discovery Development Process
Lecture 2Investigational New Drug Application (INDA)
Lecture 3New Drug Application (NDA) 
Lecture 4Basic concept and understanding of the Generic Drug
Lecture 5Abbreviated New Drug Application (ANDA)
Lecture 6Handling of orange book
Lecture 7Complete Response Letter | Key understanding | Management and Action Plan
Lecture 8Detailed understanding on expedited review
Lecture 9Patent & Exclusivity - Strategic Understanding | Patent Restoration| Orphan Drug Exclusivity (ODE) | NCE & NCI Exclusivity
Lecture 10Clinical Trials Terminologies 
Lecture 11Handling of orange book
Lecture 12USFDA expedited programs
Lecture 13Practical Training on INDA, NDA, ANDA filing
Lecture 14505(j) ANDA, 505(b)(2) NDA, 505(b)(1) NDA
Lecture 15Authorized Generics: Key Understanding
Lecture 16Exploratory IND Vs. Traditional IND
Lecture 17Patents Vs. exclusivity 
Lecture 18Orphan Drug Designation
Lecture 19Advance Learning on 505B2 Pathway
Lecture 20Chemistry, Manufacturing & Controls 
Lecture 21Patent & Exclusivity - Strategic Understanding | Patent Restoration| Orphan Drug Exclusivity (ODE) | NCE & NCI Exclusivity | GAIN Exclusivity | Pediatric Exclusivity | 180 days exclusivity
Lecture 22Review on Drug Discovery and Development 
Section 2Drug Regulation and Registration in ASEAN countries | Advance Strategic Planning
Lecture 23ASEAN Countries | Geographical Overview
Lecture 24ASEAN Region - Pharma Business
Lecture 25Prerequisite for export in ASEAN countries
Lecture 26The Pharmaceutical Inspection Co-operation Scheme
Lecture 27CPP Requirements for Drug Registration in ASEAN countries
Lecture 28Dossier Requirements - ACTD/CTD Acceptability
Lecture 29Pharmacopoeias Acceptability
Lecture 30Harmonization of Technical Guidelines 
Lecture 31Product Labelling
Lecture 32Post Approval Changes (Variations) requirements in ASEAN countries
Lecture 33Pharmacovigilance and Risk Management Plan (RMP)
Lecture 34Timeline of Drug Registration Approval
Lecture 35Drug Registration and Regulation in Brunei
Lecture 36Drug Registration and Regulation in Cambodia
Lecture 37ASEAN Drug Regulations : Comparison Study | Guidelines | Pharmaceutical products Regulatory Submissions | Pharmacopoeia Requirements | stability requirements | Pharmacovigilance | Product labeling | Drug variation information
Lecture 38Drug Registration and Regulation Singapore | Strategic Pathways for Marketing Authorization | Screening, Evaluation of MA applications | Variations Classifications and Management
Section 3Drug Regulation and Registration in ASEAN countries | Advance Strategic Planning
Lecture 39CMC - Funamental understanding
Lecture 40CMC Dossier & Compliance Management
Lecture 41Introduction to Common Technical Document (CTD)
Lecture 42Asean Common Technical Document (ACTD) 
Lecture 43Advance Practical Training on Dossier Preparation focusing on drug registration in export countries 
Lecture 44Modules on Stability Study : Stability Study - Fundamental Understanding | Interchangebility | Reports | API & FPP Stability Study
Lecture 45Key Consideration for Drug Master File Preparation and Submission 
Lecture 46Practical Understanding on Drug Master File Preparation and Submission
Lecture 47Site Master File - Detailed Understanding 
Lecture 48DMF Completeness Assessment
Lecture 49Importance of effective dossier management
Lecture 50Discussion on 85 common deficiencies in CTD submission dossier
Lecture 51Data Integrity issues in Pharmaceutical Industry : Detailed Understanding 
Lecture 52Establishment Inspection Report | 483 Observations | USFDA Warning Letter | Handling of FDA inspection | Closing of Warning Letter 
Lecture 53Electronic Batch Record for effective compliance management | Key Understanding | Functionalities | Importance in managing data integrity
Lecture 54Comparsion of Drug Regulatory Requirements for various regions
Lecture 55Reference: Countries Classification based on climate and stability zone
Lecture 56Stability Zone Finder
Lecture 57Stability Study requirements for drug registration in ASEAN countries
Lecture 58Stability Studies : Case discussions
Lecture 59Accelerated and intermediate testing conditions
Lecture 60Long Term Stability Testing Requirements
Lecture 61Stability Study : Testing Frequency
Lecture 62Stability Study: Bracketing
Lecture 63Matrixing
Lecture 64Stability Study Protocol Development - Dosage form: Capsule
Lecture 65Stability Data Sheet
Lecture 66Dossier Stability Test
Section 4Plant Inspection and Certifications
Lecture 67Certification Pharmaceutical Companies / Plants 
Lecture 68Premises & Plant Layout Designing
Lecture 69Sanitation and Hygiene
Lecture 70Equipment Modules
Lecture 71Production Modules
Lecture 72Documentation
Lecture 73Quality Control
Lecture 74Product Complaint
Lecture 75Storage Module
Section 5Bioequivalence Study | PKPD Study
Lecture 76PKPD in Drug Discovery | PK-PD trial | Understanding PKPD from regulatory perspective in drug approval process
Lecture 77Bioequivalence Study | Study design | Different types of BE Studies
Lecture 78Bioequivalence Study | Study design | Parallel Study | Crossover study design | Other alternative study designs | Blood Sampling Planning  | Analyte | Bioanalytical Methods Validation  | Statistical Model  | Ln Transformation  | Dose normalisation | Confidence interval acceptance criteria
Lecture 79Biopharmaceutical Classification System (BCS) | Types | Biowaivers | BCS tool for drug development and regulatory submission
Lecture 80Bioequivalence Study - Discussion - Timeline of stability study and bioequivalence study 
Lecture 81Bioequivalence Study - Discussion - Dissolution Testing
Lecture 82Bioequivalence Study - Generic Approval and Additives Labeling Requirements 
Section 6Variation Filing
Lecture 83Introduction to Variation Management | Reasons for Variation | Working in Variation Department 
Lecture 84Variation Classification | Basis of Classification | US and EU Variation Classification | Other region variation guideline.